Design and rational of the OPTIMA Study: Retreatment or Step-Up Therapy with Omalizumab in Patients with Chronic Idiopathic/Spontaneous Urticaria (CIU/CSU). J of Skin. 2017;1(3.1):s125. doi:10.25251/skin.1.supp.124